CME Outfitters - Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation

Credit type

Welcome, .

What type(s) of continuing education credit would you like to receive?

Physicians (CME), AMA PRA Category 1 Credits(s)™ - MD/DO Physicians only

Dental

- License #

Pharmacists (ACPE)

- NABP e-Profile #

- date of birth (MM/DD)

Physicians (ABIM MOC)

- ABIM e-Profile #

- date of birth (MM/DD/YYYY)

ABO (MOC)

- ABO#

- date of birth (MM/DD/YYYY)

Surgery (ABS)

- date of birth (MM/DD)

Note: By continuing and submitting for credit you give CME Outfitters permission to share this information with the ACCME and the ABS

Pharmacy Technician

- NABP CPE ID#

- date of birth (MM/DD)

ABP (MOC)

- ABP#

- date of birth (MM/DD/YYYY)

Others (Attendance Certificate)

Participation info

How many credits are you claiming for this activity? credit hours

How did you hear about this activity?

Begin test

SN-135-022221-08 Post-Test

Participants are required to complete the post-test to assess their learning and achievement of the educational objectives.

To obtain a certificate or statement of credit, you must complete both the post-test and evaluation.

A minimum score of 75% on the post-test is required to receive credit.

Continue

Commitment

As a result of my participation in this activity, I will commit to:

Select appropriate individualized treatment regimens for my patients based on the latest clinical data

Yes No

Objectives

The course met the stated objectives

Assess the mechanistic rationale for novel and emerging treatments for psoriatic arthritis, including key clinical efficacy and safety data for targeted treatments.

Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

Content

Please rate your level of agreement with the following statements.

This activity...
Helped me to have a better understanding of the topic(s).

Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

Assisted me to consider using the information in a different way to improve my practice.

Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

Provided me with resources I can use in my daily practice or with my patients.

Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

Will support my routine clinical practice to deliver evidence-based, best practice that improves patient health outcomes.

Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

Faculty

Rate the quality of the faculty member(s) listed below, from 5 (Excellent) to 1 (Poor).

Credibility

Will you change the way you practice based on this activity?

Yes

Do you feel the activity was balanced and objective?

Yes

Do you feel the activity was free of commercial bias?

Yes

Approximately what percent of this content was NEW to you?

As compared to other CME activities you have participated in the past six months, do you believe this activity:

	Increased your knowledge
	Will improve patient outcomes in your practice

What I liked about this activity...?
(select all that apply)

	It allowed me to interact with my peers and faculty
	It provided feedback throughout the activity
	It provided information in ways that I can review again later
	It gave me the opportunity to apply information to realistic scenarios that I confront in my practice
	It facilitated the sharing of experiences and best practices

In the past six months, how many CME programs have your participated in?

What was the most useful information you gained from this activity?

Suggested topics for future activities:

General comments/suggestions:

Continue

For best result, set your printer's page setup to landscape (wide) page orientation on the next screen.

CME Outfitters, LLC, is accredited by
the Accreditation Council for Continuing Medical Education
to provide continuing medical education for physicians.

CME Outfitters, LLC, certifies that

has participated in the titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation

and is awarded AMA PRA Category 1 Credit(s)™.

		12/21/2024
Susan Yarbrough, MPA Senior Director, Educational Excellence		Date printed

1395 Piccard Drive, Suite 370 • Rockville, MD 20850
www.cmeoutfitters.com • 877.CME.PROS

This continuing nursing education activity was approved by
the California Board of Registered Nursing. The provider number is CEP 15510.

CME Outfitters, LLC, certifies that

has participated in the educational activity titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation

and is awarded contact hours.
This document must be retained by the licensee for a period of four years after the course concludes.

		12/21/2024
Susan Yarbrough, MPA Senior Director, Educational Excellence		Date printed

1395 Piccard Drive, Suite 370 • Rockville, MD 20850
www.cmeoutfitters.com • 877.CME.PROS

CME Outfitters, LLC, verifies that

has successfully completed the continuing pharmacy education activity titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation

ACPE UAN

Continuing Pharmacy Education: Contact Hours, CEUs

Activity Type:

		12/21/2024
Susan Yarbrough, MPA Senior Director, Educational Excellence		Date printed

1395 Piccard Drive, Suite 370 • Rockville, MD 20850
www.cmeoutfitters.com • 877.CME.PROS

CME Outfitters, LLC, verifies that

has successfully completed the continuing pharmacy education activity titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation

ACPE UAN

Continuing Pharmacy Education: Contact Hours, CEUs

Activity Type:

		12/21/2024
Susan Yarbrough, MPA Senior Director, Educational Excellence		Date printed

1395 Piccard Drive, Suite 370 • Rockville, MD 20850
www.cmeoutfitters.com • 877.CME.PROS

CME Outfitters, LLC, verifies that

has successfully completed the continuing pharmacy education activity titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation

ABO

Continuing ABO Education: Contact Hours, CEUs

Activity Type:

		12/21/2024
Susan Yarbrough, MPA Senior Director, Educational Excellence		Date printed

1395 Piccard Drive, Suite 370 • Rockville, MD 20850
www.cmeoutfitters.com • 877.CME.PROS

CME Outfitters, LLC, verifies that

has successfully completed the continuing pharmacy education activity titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation

Pharmacy Technician (PT)

Continuing PT Education: Contact Hours, CE

		12/21/2024
Susan Yarbrough, MPA Senior Director, Educational Excellence		Date printed

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

1395 Piccard Drive, Suite 370 • Rockville, MD 20850
www.cmeoutfitters.com • 877.CME.PROS

CME Outfitters, LLC, verifies that

has successfully completed the continuing pharmacy education activity titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation

ABO

Continuing ABO Education: Contact Hours, CEUs

Activity Type:

		12/21/2024
Susan Yarbrough, MPA Senior Director, Educational Excellence		Date printed

certifies that

, DDS

has participated in the activity titled:

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation

Conducted in Houston, TX

Instructor: Ameet Nagpal, MD, MS, M.Ed

This participant attended hour.

		Saturday, December 21, 2024
Terri Ashmeade, MD Associate Dean USF Health, Continuing Professional Development (Provider #50-2970)

CME Outfitters, LLC
1395 Piccard Drive, Suite 370
Rockville, MD 20850
www.cmeoutfitters.com
877.CME.PROS

Registration Number

Continuing Education Certificate of Completion

Provider:

CME Outfitters,
LLC10319 Westlake Dr. #106
Bethesda, MD 20817

Phone: 614-328-4500

Licentiates Name:

License Number:_______

has participated in the activity titled Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation

Units earned: CMEO Snack

All of the information contained on this certificate is truthful and accurate.

		12/21/2024
Susan Yarbrough, MPA Senior Director, Educational Excellence		Date

		12/21/2024
Licentiates Signature		Date

1395 Piccard Drive, Suite 370 • Rockville, MD 20850
www.cmeoutfitters.com • 877.CME.PROS

This program is approved by the National Association of Social Workers
(Approval #886407722-) for continuing education contact hours.

CME Outfitters, LLC, certifies that

has participated in the educational activity titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation

and is awarded contact hours

Presenters:

		12/21/2024
Susan Yarbrough Senior Director, Educational Excellence		Date printed

www.cmeoutfitters.com • 877.CME.PROS

CME Outfitters, LLC, certifies that

has participated in the educational activity titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation
On 2/22/2021
and is awarded
of AAPA Category 1 CME credit hours.

AAPA

This program was planned in accordance with AAPA's CME Standards for Enduring Programs and for Commercial Support of Enduring Programs.

		12/21/2024
Susan Yarbrough Senior Director, Educational Excellence		Date printed

1395 Piccard Drive, Suite 370 • Rockville, MD 20850
www.cmeoutfitters.com • 877.CME.PROS

This is to certify that

has attended and successfully completed the educational activity

		12/21/2024
Susan Yarbrough Senior Director, Educational Excellence		Date printed

1395 Piccard Drive, Suite 370 • Rockville, MD 20850
www.cmeoutfitters.com • 877.CME.PROS

CCMC Approved Activity:

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation

Approval number:

This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM board certified case managers.
The course listed above was completed

The course is approved for CE contact hour(s). To claim these clock hours, log into your CE Center account at www.ccmcertification.org.

		12/21/2024
Susan Yarbrough Senior Director, Educational Excellence		Signature/Date printed

1395 Piccard Drive, Suite 370 • Rockville, MD 20850
www.cmeoutfitters.com • 877.CME.PROS

CME Outfitters is approved by the American Psychological Association
to sponsor continuing education for psychologists.
CME Outfitters maintains responsibility for this program and its content.

CME Outfitters, LLC, certifies that

has participated in the educational program titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation

and is awarded CE credit hours.

		12/21/2024
Susan Yarbrough Senior Director, Educational Excellence		Date printed

USF Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME)
to provide Continuing Medical Education for physicians.

CME Outfitters, LLC, certifies that

has participated in the educational activity titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation

and is awarded AMA PRA Category 1 Credit(s)™.

		12/21/2024
Susan Yarbrough Senior Director, Educational Excellence		Date printed

CME Outfitters, LLC, is accredited by
the Accreditation Council for Continuing Medical Education
to provide continuing medical education for physicians.

CME Outfitters, LLC, certifies that

has participated in the titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation

This activity was designated for AMA PRA Category 1 Credit(s)™.

		12/21/2024
Susan Yarbrough Senior Director, Educational Excellence		Date printed

www.cmeoutfitters.com • 877.CME.PROS

CME Outfitters, LLC, is accredited by
the Accreditation Council for Continuing Medical Education
to provide continuing medical education for physicians.

CME Outfitters, LLC, certifies that

has participated in the titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation

and is awarded AMA PRA Category 1 Credit(s)™.

		12/21/2024
Susan Yarbrough Senior Director, Educational Excellence		Date printed

1395 Piccard Drive, Suite 370 • Rockville, MD 20850
www.cmeoutfitters.com • 877.CME.PROS

CME Outfitters is approved by the American Psychological Association
to sponsor continuing education for psychologists.
CME Outfitters maintains responsibility for this program and its content.

CME Outfitters, LLC, certifies that

has participated in the educational program titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation

and is awarded CE credit hours.

		12/21/2024
Susan Yarbrough Senior Director, Educational Excellence		Date printed

1395 Piccard Drive, Suite 370 • Rockville, MD 20850
www.cmeoutfitters.com • 877.CME.PROS

CME Outfitters, LLC, verifies that

has successfully completed the continuing pharmacy education activity titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation

ACPE UAN

Continuing Pharmacy Education: Contact Hours, CEUs

Activity Type: knowledge-based

		12/21/2024
Susan Yarbrough Senior Director, Educational Excellence		Date printed

www.cmeoutfitters.com • 877.CME.PROS

CME Outfitters, LLC, certifies that

has participated in the educational activity titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation
On 2/22/2021
and is awarded continuing education credits.

		12/21/2024
Susan Yarbrough Senior Director, Educational Excellence		Date printed

www.cmeoutfitters.com • 877.CME.PROS

CME Outfitters, LLC, certifies that

has participated in the educational activity titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation
On 2/22/2021
and is awarded continuing education credits.

		12/21/2024
Susan Yarbrough Senior Director, Educational Excellence		Date printed

www.cmeoutfitters.com • 877.CME.PROS

CME Outfitters, LLC, certifies that

has participated in the educational activity titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation
On 2/22/2021
and is awarded of AAPA Category 1 CME credit hours.

AAPA

This program was planned in accordance with AAPA's CME Standards for Enduring Programs and for Commercial Support of Enduring Programs.

		12/21/2024
Susan Yarbrough Senior Director, Educational Excellence		Date printed

www.cmeoutfitters.com • 877.CME.PROS

CME Outfitters, LLC, certifies that

has participated in the educational activity titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation
On 2/22/2021
and is awarded contact hours.

		12/21/2024
Susan Yarbrough Senior Director, Educational Excellence		Date printed

www.cmeoutfitters.com • 877.CME.PROS

CME Outfitters, LLC, certifies that

has participated in the educational activity titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation
On 2/22/2021
and is awarded contact hours.

		12/21/2024
Susan Yarbrough Senior Director, Educational Excellence		Date printed

www.cmeoutfitters.com • 877.CME.PROS

CME Outfitters, LLC, certifies that

has participated in the educational activity titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation
On 2/22/2021
and is awarded credit hours.

		12/21/2024
Susan Yarbrough Senior Director, Educational Excellence		Date printed

www.cmeoutfitters.com • 877.CME.PROS

CME Outfitters, LLC, verifies that

has participated in the material titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation

This activity is designated for .25 contact hours

		12/21/2024
Susan Yarbrough Senior Director, Educational Excellence		Date printed

California Residents: This continuing nursing education activity was approved by the California Board of Registered Nursing.
CME Outfitters LLC’s provider number is CEP 15510.

1395 Piccard Drive, Suite 370 • Rockville, MD 20850
www.cmeoutfitters.com • 877.CME.PROS

CME Outfitters, LLC, certifies that

has participated in the educational activity titled

Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation
On 2/22/2021

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

		12/21/2024
Susan Yarbrough - Senior Director, Educational Excellence		Date printed

A.	Methotrexate, apremilast, tofacitinib, ustekinumab
B.	Methotrexate, secukinumab, tofacitinib, ustekinumab, guselkumab
C.	Tofacitinib, guselkumab, ixekizumab, ustekinumab, infliximab
D.	Tofacitinib, apremilast guselkumab, ixekizumab, ustekinumab, infliximab

A.	There are several JAK inhibitors FDA-approved for psoriatic arthritis
B.	JAK inhibitors work by inhibiting the JAK pathway by inhibiting JAK intracellularly inhibiting the activation of STAT and the downstream activation of mediators of inflammation
C.	The JAK-STAT pathway is instrumental in reducing pain and inflammation
D.	When Janus Kinase is activated it is phosphorylated blocking binding to STAT augmenting the cycle of inflammation

A.	Selective inhibition of JAK1
B.	Selective inhibition of JAK2
C.	Selective inhibition of JAK3
D.	Selective inhibition of tyrosine kinase 2

A.	Deucravacitinib 6 mg and 12 mg QD compared to placebo achieved statistical significance in response rates as measured by ACR 20/50/70 at 16 weeks
B.	Deucravacitinib 6 mg and 12 mg QD compared to placebo achieved statistical significance in response rates as measured by ASAS 20/50/70
C.	Deucravacitinib 6 mg and 12 mg QD compared to placebo achieved statistical significance in response rates as measured by PAAP change from baseline at 16 weeks

Please Sign In

Terms of Service

Physicians (CME), AMA PRA Category 1 Credit(s)™ - MD/DO Physicians only

Pharmacy (ACPE)